Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 222 of 5804
-
New pill could help babies fight RSV faster
Disease control Recruiting nowZelicapavir is a novel, orally administered, nonfusion replication inhibitor of RSV. It is being investigated in this Phase 2 study (EDP 938-203) as a potential treatment for RSV infection in both hospitalized and non-hospitalized children aged ≥28 days to ≤36 months who present …
Phase: PHASE2 • Sponsor: Enanta Pharmaceuticals, Inc • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New hope for tough lymphoma: antibody combo targets cancer after CAR t fails
Disease control Recruiting nowThis phase II trial tests the safety and side effects of glofitamab and obinutuzumab and how well they work in treating patients with mantle cell lymphoma that has come back after a period of improvement (relapsed) or that has not responded to previous treatment (refractory) afte…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Suction device may improve outcomes in heart attack patients with large clots
Disease control Recruiting nowThe CAPTURE AMI trial is an investigator-initiated, single-centre, two-arm, randomised controlled trial. Patients aged ≥ 18 years who present with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI) will be enrolled after angiog…
Phase: PHASE2, PHASE3 • Sponsor: Oxford University Hospitals NHS Trust • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Engineered immune cells take aim at stubborn blood disorder
Disease control Not yet recruitingA Study of Metabolically Armed Autologous CD19 CAR T-Cell Therapy (META 10-19) in Patients with Relapsed/Refractory Autoimmune Hemolytic Anemia
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can targeted supplements ease migraine suffering? new trial investigates
Disease control Not yet recruitingThe purpose of this study is to evaluate the impact of the Migraceutics® phase-specific dietary supplement regimen on quality of life, work productivity, and biomarkers in adult migraineurs.
Phase: NA • Sponsor: Miracle Wellness LLC • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New combo therapy aims to boost lung cancer treatment
Disease control Recruiting nowMonocentric study composed by 2 steps : 1. First step is a phase I with the aim of establish the recommended dose of mirdametinib administration (2 or 4 mg twice a day for 7 or 14 days per cycle for the 4 first of carboplatin/pemetrexed/pembrolizumab treatment) 2. Second step is…
Phase: PHASE1, PHASE2 • Sponsor: Centre Georges Francois Leclerc • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New hope for brain metastases: drug combo targets hard-to-treat breast cancer
Disease control Recruiting nowThe purpose of this study is to evaluate the intracranial response rate of a combination of asciminib/trastuzumab for the treatment of patients with metastatic HER2+ breast cancer with brain metastases.
Phase: PHASE1, PHASE2 • Sponsor: Duke University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New triple therapy aims to slow advanced lung cancer
Disease control Recruiting nowThis is a single center, phase Ib/II study combining an anti-PD-1 antibody and an anti-CTLA-4 antibody with IL-15. It is testing the hypothesis that the addition of nogapendekin alfa inbakicept to nivolumab and ipilimumab will augment the clinical activity of those two drugs.
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Experimental CAR t therapy takes on Hard-to-Treat prostate cancer
Disease control Recruiting nowThis study will test a study drug called BPX-601, a CAR-T cell product manufactured from the patient's own T-cells, to see if it can help treat advanced prostate cancer. BPX-601 is a drug that is only used in clinical studies. The study is looking at: * What side effects BPX-60…
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New lozenge aims to ease radiation mouth sores for hours
Symptom relief Recruiting nowMost patients who receive radiation therapy for head and neck cancer develop painful sores in the mouth called oral mucositis. For many of them, these sores are severe and result in debilitating pain. The sores usually start in the third week of radiation and last aboutfive weeks…
Phase: PHASE3 • Sponsor: OncoZenge AB • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
One-Time brain injection targets genetic form of Parkinson's
Disease control Not yet recruitingThis is a prospective, single-arm, single-dose clinical study designed to evaluate the safety, tolerability, efficacy, immunogenicity, pharmacodynamic (PD) and pharmacokinetic (PK) profiles of LY-N001 Injection in patients with moderate-to-advanced Parkinson's disease carrying GB…
Phase: EARLY_PHASE1 • Sponsor: Lingyi Biotech Co., Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Warm liver transplants: could ditching the ice bath reduce organ damage?
Disease control Recruiting nowThe ARANMP-LT study is a multicenter, open-label, randomized, parallel-group, non-inferiority clinical trial designed to evaluate whether avoiding graft recooling after normothermic machine perfusion (NMP) improves early outcomes following liver transplantation. Although graft re…
Phase: NA • Sponsor: The Mediterranean Institute for Transplantation and Advanced Specialized Therapies • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New pill combo aims to tame type 2 diabetes
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron alone or in combination with dapagliflozin compared with placebo in adults with type 2 diabetes mellitus (T2DM) inadequately managed with lifestyle management alone or treated with oth…
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Probiotic pill aims to stop recurrent cystitis without antibiotics
Prevention Not yet recruitingRecurrent cystitis is a common condition in menopausal women and is associated with impaired quality of life and increased antibiotic use. This randomized, double-blind, placebo-controlled clinical trial aims to evaluate the efficacy and safety of Colipral® in preventing recurren…
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Prevention
Last updated Jul 08, 2026 00:00 UTC
-
Engineered immune cells take aim at debilitating muscle weakness
Disease control Not yet recruitingThis is a Phase I, single-arm, open-label, dose-escalation and dose-expansion study. This is an exploratory clinical study of universal STAR-T cell injection in patients with refractory generalized myasthenia gravis (GMG). Approximately 10-24 participants aged 18-65 years (inclu…
Phase: PHASE1 • Sponsor: Daishi Tian • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Brain wave alert: new tool could predict delirium hours before it strikes after heart surgery
Knowledge-focused Not yet recruitingAfter heart surgery, up to half of all patients may develop a state of sudden confusion called postoperative delirium. This condition can lead to longer time on a breathing machine, extended stays in the intensive care unit (ICU), and a slower overall recovery. Currently, doctors…
Sponsor: Southeast University, China • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Lifestyle makeover could slash Alzheimer's risk in genetically vulnerable seniors
Prevention Not yet recruitingWellderly Brain is a randomized, direct-to-participant trial evaluating whether a virtually delivered, multidomain lifestyle coaching intervention can favorably impact plasma biomarkers of Alzheimer's disease (AD) in adults aged 60-80 with APOE4 positivity or elevated polygenic r…
Phase: NA • Sponsor: Scripps Translational Science Institute • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
New hope: Alzheimer's trial targets tau tangles to slow memory loss
Disease control Recruiting nowThe goal of the Alzheimer's Tau Platform (ATP) is to evaluate the safety and effectiveness of tau-directed therapies, alone or in combination with the anti-amyloid monoclonal antibody, donanemab, in adults aged 50-80 with late preclinical or early prodromal Alzheimer's disease. …
Phase: PHASE2 • Sponsor: Paul S. Aisen • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New diabetes pill elecoglipron faces final test in 600-Patient trial
Disease control Not yet recruitingThe purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with placebo in adults with Type 2 Diabetes Mellitus (T2DM), treated with a background insulin and other background glucose-lowering medication(s)
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Diabetes duo: could a Two-Pill combo tame blood sugar better than one?
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron and dapagliflozin in combination, compared with elecoglipron alone and dapagliflozin alone, in adults with type 2 diabetes mellitus (T2DM) inadequately managed with lifestyle managemen…
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC